Capitol Hill House FY24 spending bill slashes NIH by 6%, NCI by 3% July 14, 2023Vol.49 No.28By Paul Goldberg
Guest Editorial Evaluation of COE requires a holistic approach; avoiding two fundamental fallacies July 14, 2023Vol.49 No.28By George J. Weiner
Guest Editorial The new breast cancer screening guidelines are not enough to save Black womenA breast surgical oncologist and breast radiologist weigh in July 14, 2023Vol.49 No.28By Vivian Jolley Bea and Kemi Babagbemi
Conversation with The Cancer Letter Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunityThe finding may alter biology textbooks July 07, 2023Vol.49 No.27By Jacquelyn Cobb
Can ctDNA be used as an endpoint for cancer drug development?Friends collaboration to present initial results July 11 July 07, 2023Vol.49 No.27By Matthew Bin Han Ong
Guest Editorial Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities July 07, 2023Vol.49 No.27By Kim F. Rhoads, Folakemi T. Odedina, Monica L. Baskin, Vanessa B. Sheppard, Hayley S. Thompson, Kimlin Tam Ashing and Charnita Zeigler-Johnson
FreeObituary Susan Love, a transformative leader in breast cancer movement, dies at 75She intuitively understood the right thing to do—and then just did it July 07, 2023Vol.49 No.27By Frances M. Visco
FreeIn the Archives Remembering Susan Love, breast cancer oncologist and advocate July 07, 2023Vol.49 No.27
Conversation with The Cancer Letter Robert Winn: Overreaction to the Supreme Court ruling that bars affirmative action is a greater threat than the ruling itself June 30, 2023Vol.49 No.26By Paul Goldberg and Matthew Bin Han Ong
